Two papers published online today in the journal Nature (abstracts available here and here) show us why this is the case at least in a subset of cases in individuals with BRCA2 mutations.
Mechanism of Cisplatin-Resistance in BRCA2-Related Ovarian Cancers
Posted on February 10, 2008 Written by 2 Comments